Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 171 Bevacizumab 106 Radiotherapy 87 Radiation 38 Cyclophosphamide 38 Etoposide 34 Carboplatin 34 Magnetic Resonance Spectroscopy 32 Irinotecan 32 Radiosurgery 27 Vincristine 25 pembrolizumab 24 Everolimus 23 Cisplatin 23 Nivolumab 22 Radiotherapy, Intensity-Modulated 19 Isotretinoin 19 Filgrastim 19 Erlotinib Hydrochloride 19 Topotecan 18 Lomustine 17 Vorinostat 16 Doxorubicin 16 Granulocyte Colony-Stimulating Factor 15 sargramostim 14 antineoplaston A10 13 Radiotherapy, Conformal 13 antineoplaston AS 2-1 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 dinutuximab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × gadopiclenol × CNS × Clear all

NCT06057168 2026-01-29

GDX-44-016

Guerbet

Phase 3 Completed

138 enrolled 7 charts

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡